X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (28) 28
index medicus (24) 24
humans (23) 23
diabetes (16) 16
peripheral vascular disease (16) 16
rats (16) 16
angiotensin (15) 15
prorenin (15) 15
renin (14) 14
male (13) 13
nonproteolytic activation (12) 12
coronary vessels - drug effects (11) 11
coronary vessels - physiology (11) 11
female (11) 11
angiotensin-ii (10) 10
blood-pressure (10) 10
bradykinin (10) 10
dose-response relationship, drug (9) 9
hypertension (9) 9
middle aged (9) 9
receptor (9) 9
renin-angiotensin system (9) 9
renin/prorenin receptor (9) 9
adult (8) 8
receptors, cell surface - metabolism (8) 8
renin - metabolism (8) 8
renin receptor (8) 8
inhibition (7) 7
pharmacology & pharmacy (7) 7
smooth-muscle-cells (7) 7
transgenic rats (7) 7
vasoconstriction - drug effects (7) 7
vasodilation - drug effects (7) 7
adolescent (6) 6
aged (6) 6
bradykinin - pharmacology (6) 6
expression (6) 6
in vitro techniques (6) 6
nitric oxide (6) 6
physiological aspects (6) 6
renin - antagonists & inhibitors (6) 6
swine (6) 6
vasodilation - physiology (6) 6
amides - pharmacology (5) 5
angiotensin ii - pharmacology (5) 5
biological factors - physiology (5) 5
biphenyl compounds - pharmacology (5) 5
cells, cultured (5) 5
fumarates - pharmacology (5) 5
nitric-oxide (5) 5
oligopeptides - pharmacology (5) 5
s-nitrosothiols (5) 5
tetrazoles - pharmacology (5) 5
vascular smooth-muscle (5) 5
angiotensin ii - metabolism (4) 4
arteries (4) 4
endothelium-derived hyperpolarizing factor (4) 4
kidney (4) 4
microcirculation - drug effects (4) 4
nitric oxide - physiology (4) 4
plasma prorenin (4) 4
pyridines - pharmacology (4) 4
rat (4) 4
rats, sprague-dawley (4) 4
rats, transgenic (4) 4
renin-angiotensin system - physiology (4) 4
signal transduction (4) 4
vasoconstriction (4) 4
vasoconstrictor agents - pharmacology (4) 4
activation (3) 3
aldosterone (3) 3
aldosterone - metabolism (3) 3
aliskiren (3) 3
angiotensin-converting enzyme (3) 3
animals, genetically modified (3) 3
at receptors (3) 3
bkca channels (3) 3
blood pressure - physiology (3) 3
bradykinin-induced relaxation (3) 3
cardiac & cardiovascular systems (3) 3
cardiovascular disease (3) 3
child (3) 3
cyclic gmp - metabolism (3) 3
edhf (3) 3
endothelium (3) 3
endothelium, vascular - drug effects (3) 3
extracellular signal-regulated map kinases - metabolism (3) 3
health aspects (3) 3
humanrenin receptor (3) 3
imidazoles - pharmacology (3) 3
mediated vasodilation (3) 3
medicine (3) 3
muscle, smooth, vascular - drug effects (3) 3
muscle, smooth, vascular - metabolism (3) 3
nephropathy (3) 3
neprilysin inhibition (3) 3
ng-nitroarginine methyl ester - pharmacology (3) 3
peptides (3) 3
prorenin receptor (3) 3
protein-kinase (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 05/2018, Volume 827, pp. 112 - 116
Protein kinase G (PKG) Iα mediates the cyclic guanosine monophosphate-mediated vasodilatory effects induced by NO. Endothelium-derived hyperpolarizing factors... 
Protein kinase G Iα | Endothelium-derived hyperpolarizing factors | S-nitrosothiols | Thioredoxin reductase | Soluble guanylyl cyclase | Protein kinase G I alpha | RAT | MOUSE AORTA | ANGIOTENSIN-II | CORONARY-ARTERIES | BRADYKININ-INDUCED RELAXATION | RECOGNITION SITES | PHARMACOLOGY & PHARMACY | EDHF | NITROSOCYSTEINE
Journal Article
European journal of pharmacology, ISSN 0014-2999, 03/2018, Volume 827, pp. 112 - 116
Protein kinase G (PKG) Iα mediates the cyclic guanosine monophosphate-mediated vasodilatory effects induced by NO. Endothelium-derived hyperpolarizing factors... 
Journal Article
Journal Article
Cardiovascular Research, ISSN 0008-6363, 04/2012, Volume 94, Issue 1, pp. 136 - 143
The aim of this study was to investigate the aldosteroneangiotensin (Ang) II interaction in human coronary microarteries (HCMAs). HCMAs, obtained from 75... 
GPR30 | EGF receptor | 17β-oestradiol | Aldosterone | Human coronary arteries | CARDIAC & CARDIOVASCULAR SYSTEMS | AT RECEPTOR | NITRIC-OXIDE SYNTHASE | PROTEIN-KINASE | REGULATED KINASE 1/2 | ESTROGEN-RECEPTOR | BLOOD-PRESSURE | MINERALOCORTICOID RECEPTOR | S-NITROSYLATION | SMOOTH-MUSCLE-CELLS | HYPERPOLARIZING FACTORS | 17-oestradiol
Journal Article
Journal Article
Journal Article
Journal of Hypertension, ISSN 0263-6352, 12/2007, Volume 25, Issue 12, pp. 2441 - 2453
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 04/2009, Volume 302, Issue 2, pp. 213 - 218
Morbidity and mortality of diabetes mellitus are strongly associated with cardiovascular disease including nephropathy. A discordant tissue renin-angiotensin... 
(Pro)renin receptor | Cardiovascular disease | TGF-β | Diabetes | Renin-angiotensin system | Prorenin
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 04/2009, Volume 302, Issue 2, p. 213
Morbidity and mortality of diabetes mellitus are strongly associated with cardiovascular disease including nephropathy. A discordant tissue renin-angiotensin... 
Complications and side effects | Mortality | Angiotensin | Bone morphogenetic proteins | Diabetes | Transforming growth factors
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 04/2009, Volume 302, Issue 2, pp. 213 - 218
Morbidity and mortality of diabetes mellitus are strongly associated with cardiovascular disease including nephropathy. A discordant tissue renin-angiotensin... 
Elevated | Receptors | Pathways | Precursors | Searching | Mortality | Stimulation | Diabetes
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e100954
textabstractDysfunction of renin-angiotensin system (RAS) contributes to the pathogenesis of diabetic retinopathy (DR). Prorenin, the precursor of renin is... 
PLASMA PRORENIN | IN-VITRO | NONPROTEOLYTIC ACTIVATION | BINDING-KINETICS | HUMAN (PRO)RENIN RECEPTOR | MULTIDISCIPLINARY SCIENCES | SMOOTH-MUSCLE-CELLS | ANGIOTENSIN-II | HANDLE-REGION PEPTIDE | (MREN-2)27 RAT | MULLER CELLS | Blood Pressure | Diabetic Retinopathy - drug therapy | Apoptosis - genetics | Fumarates - administration & dosage | Diabetic Retinopathy - pathology | Receptors, Cell Surface - antagonists & inhibitors | Retinal Ganglion Cells - metabolism | Gliosis - pathology | Renin - genetics | Inflammation Mediators - metabolism | Disease Models, Animal | Amides - pharmacology | Cytokines - metabolism | Gliosis - metabolism | Rats | Receptors, Cell Surface - metabolism | Mice, Transgenic | Diabetic Retinopathy - metabolism | Diabetic Retinopathy - genetics | Animals | Renin - antagonists & inhibitors | Fumarates - pharmacology | Oligopeptides - administration & dosage | Oligopeptides - pharmacology | Amides - administration & dosage | Diabetic retinopathy | Genetic engineering | Cytokines | Angiotensin | Drugs | Retinopathy | Peptides | Pathogenesis | Streptozocin | Transgenic | Retina | Smooth muscle | Kinases | Renin | Rodents | Inhibition | Capillaries | Angiotensin II | Hypertension | Internal medicine | Diabetes mellitus | Pharmacology | Inflammation | siRNA | Tumor necrosis factor-α | Medicine | Gliosis | Cell death | Photoreceptors | Diabetes | Metabolic disorders | Apoptosis
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 2009, Volume 302, Issue 2, pp. 213 - 218
Morbidity and mortality of diabetes mellitus are strongly associated with cardiovascular disease including nephropathy. A discordant tissue renin–angiotensin... 
Renin–angiotensin system | (Pro)renin receptor | Prorenin | Cardiovascular disease | TGF-β 1 | Diabetes
Journal Article
Journal Article
Journal Article
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, ISSN 1470-3203, 09/2008, Volume 9, Issue 3, pp. 181 - 184
Journal Article
Hypertension, ISSN 0194-911X, 09/2012, Volume 60, Issue 3, pp. 722 - 729
Angiotensin II type 2 (AT2) receptor stimulation has been linked to vasodilation. Yet, AT2 receptor-independent hypertension and hypotension (or no effect on... 
coronary circulation | mouse | compound 21 | AT | receptor | rat | vasorelaxation | angiotensin II | Langendorff model | METABOLITES | STIMULATION | RELAXATION | AT receptor | MEDIATED VASODILATION | CORONARY VASCULAR BED | NATRIURESIS | AT RECEPTORS | NONPEPTIDE AGONIST | PERIPHERAL VASCULAR DISEASE | VASOCONSTRICTION | Mesenteric Arteries - physiology | Tetrazoles - pharmacology | Iliac Artery - drug effects | Rats, Wistar | Calcium - metabolism | Humans | Middle Aged | Receptor, Angiotensin, Type 2 - physiology | Receptor, Angiotensin, Type 2 - drug effects | Endothelium, Vascular - drug effects | Male | Mesenteric Arteries - drug effects | Angiotensin II Type 2 Receptor Blockers - pharmacology | Endothelium, Vascular - physiology | Phenylephrine - pharmacology | Biphenyl Compounds - pharmacology | Adult | Calcium Ionophores - pharmacology | Female | Models, Animal | Vasodilation - physiology | Rats, Inbred SHR | Vasoconstrictor Agents - pharmacology | Receptor, Angiotensin, Type 2 - genetics | Coronary Vessels - drug effects | Coronary Vessels - physiology | Mice, Inbred C57BL | Rats | Thiophenes - pharmacology | Imidazoles - pharmacology | Sulfonamides - pharmacology | Iliac Artery - physiology | Mice, Knockout | Animals | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology | Mice | Pyridines - pharmacology | Vasodilation - drug effects | In Vitro Techniques
Journal Article